Fort Collins, CO (PRWEB) December 3, 2008
Cellastim has proven to be a robust replacement for serum derived albumin in CHO media and can improve both the growth kinetics and productivity of CHO cell lines across a variety of chemically defined media.
Studies support InVitria's claim that its Cellastim Cellastim outperforms other chemically defined cell culture ingredients and can be used by the biopharmaceutical, mammalian cell culture, stem cell and regenerative medicine industries as a supplement for cell culture media.
Cellastim is a defined supplement that can enhance performance of chemically defined media. One study revealed that Cellastim outperformed plasma-derived human serum albumin with a 50% average increase in productivity in several chemically defined cell culture media.
"InVitria's Cellastim helps optimize cell culture media performance safely and effectively," said InVitria President Scott Deeter. "As a regulatory friendly product, Cellastim can provide researchers an option to free their cells from the risk of potentially harmful contaminants, while simultaneously enhancing cell growth and productivity."
The conversion from serum supplemented media to serum-free media for production of biopharmaceuticals in CHO cells is essential for the elimination of all animal components in the culturing media. The addition of InVitria's Cellastim offers optimal defined quality and safety for the production of biopharmaceuticals in CHO cells.
InVitria has developed defined and animal-free cell culture media components that enhance cell growth, productivity, safety and time to market for companies in the biopharmaceutical, mammalian cell culture, regenerative medicine, cell therapy, stem cell and diagnostics industry. Cellastim is an animal free component used to enhance cell growth and productivity in cell culture media.
For more information about InVitria's products or to place an order, please contact InVitria's sales and marketing team by e-mail or phone.
E-mail: info (at) InVitria.com